Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novartis Acquires Endocyte For $24 Per Share Or $2.1B In Cash By: TalkMarkets October 18, 2018 at 08:53 AM EDT Endocyte announced that it has entered into an agreement and plan of merger with Novartis AG pursuant to which Novartis will acquire Endocyte for $24 per share. Read More >> Related Stocks: Endocyte Inc Novartis Ag ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Novartis Acquires Endocyte For $24 Per Share Or $2.1B In Cash By: TalkMarkets October 18, 2018 at 08:53 AM EDT Endocyte announced that it has entered into an agreement and plan of merger with Novartis AG pursuant to which Novartis will acquire Endocyte for $24 per share. Read More >> Related Stocks: Endocyte Inc Novartis Ag ADR